| Date Filed | Type | Description |
| 10/11/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/13/2023 |
3
| Kim Yong Chan (Director) has filed a Form 3 on Baudax Bio, Inc. |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Dilmore Jillian (Corporate Controller/Secretary) has filed a Form 4 on Baudax Bio, Inc.|
Txns:
| Granted 15,467 shares
@ $0 |
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2022 |
3
| Dilmore Jillian (Corporate Controller/Secretary) has filed a Form 3 on Baudax Bio, Inc. |
| 12/23/2021 |
4
| HENWOOD GERALDINE (President and CEO) has filed a Form 4 on Baudax Bio, Inc.|
Txns:
| Paid exercise price by delivering 18,636 shares
@ $0.31, valued at
$5.8k
Granted 821,168 options to buy
@ $1.7, valued at
$1.4M
|
|
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/31/2021 |
4
| CHURCHILL WINSTON J (Director) has filed a Form 4 on Baudax Bio, Inc.|
Txns:
| Bought 100,000 shares
@ $0.6293, valued at
$62.9k
|
|
| 08/23/2021 |
4
| Casten Richard S (CFO) has filed a Form 4 on Baudax Bio, Inc.|
Txns:
| Bought 50,000 shares
@ $0.51, valued at
$25.5k
|
|
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
4
| Casten Richard S (CFO) has filed a Form 4 on Baudax Bio, Inc.|
Txns:
| Bought 25,000 shares
@ $0.7899, valued at
$19.7k
|
|
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2021 |
4
| Casten Richard S (CFO) has filed a Form 4 on Baudax Bio, Inc.|
Txns:
| Bought 25,000 shares
@ $1.4072, valued at
$35.2k
|
|
| 03/10/2021 |
4
| Casten Richard S (CFO) has filed a Form 4 on Baudax Bio, Inc.|
Txns:
| Granted 15,000 shares
@ $0
Granted 85,000 shares
@ $0
Granted 15,000 options to buy
@ $1.21, valued at
$18.2k
Granted 255,000 options to buy
@ $1.21, valued at
$308.6k
|
|
| 03/10/2021 |
3
| Casten Richard S (CFO) has filed a Form 3 on Baudax Bio, Inc. |
| 01/22/2021 |
4
| HENWOOD GERALDINE (President and CEO) has filed a Form 4 on Baudax Bio, Inc.|
Txns:
| Granted 65,435 shares
@ $0 |
|
| 01/20/2021 |
4
| Lake Ryan David (CFO) has filed a Form 4 on Baudax Bio, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 20,000 shares
@ $0
Paid exercise price by delivering 26,658 shares
@ $1.3, valued at
$34.7k
Granted 23,077 options to buy
@ $1.3, valued at
$30k
Granted 60,000 options to buy
@ $1.3, valued at
$78k
|
|
| 12/09/2020 |
4
| Lake Ryan David (CFO) has filed a Form 4 on Baudax Bio, Inc.|
Txns:
| Paid exercise price by delivering 15,064 shares
@ $1.14, valued at
$17.2k
Paid exercise price by delivering 4,845 shares
@ $1.14, valued at
$5.5k
|
|
| 12/09/2020 |
4
| HENWOOD GERALDINE (President and CEO) has filed a Form 4 on Baudax Bio, Inc.|
Txns:
| Paid exercise price by delivering 11,732 shares
@ $1.14, valued at
$13.4k
Paid exercise price by delivering 71,283 shares
@ $1.14, valued at
$81.3k
|
|
| 08/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|